加载中
NYSEHealthcareMedical - Instruments & Supplies
最新数据
US$85.31
−US$1.98 · -2.27%
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
收盘时
US$85.31
−US$1.98 · -2.27%
盘后
US$85.31
US$0.00 · 0.00%
10月12日 16:14 ET
盘中时间采用ET。市场数据可能有所延迟。
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
日内区间
当前US$85.31
52周区间
当前US$85.31
盘中时间采用ET。市场数据可能有所延迟。
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
日内区间
当前US$85.31
52周区间
当前US$85.31
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 83.25亿 USD | 82.54亿 USD | 81.97亿 USD | 81.3亿 USD | 81.71亿 USD |
| 销货成本 | 38.74亿 USD | 36.61亿 USD | 35.04亿 USD | 34.35亿 USD | 32.48亿 USD |
| 毛利 | 44.51亿 USD | 45.93亿 USD | 46.93亿 USD | 46.95亿 USD | 49.23亿 USD |
| 研究与开发 | 7.39亿 USD | 7.75亿 USD | 7.58亿 USD | 7.67亿 USD | 7.66亿 USD |
| 销售、一般及管理费用 | 30.8亿 USD | 27.82亿 USD | 22.43亿 USD | 22.35亿 USD | 22.78亿 USD |
| 营业费用 | 22.7亿 USD | 35.57亿 USD | 30.01亿 USD | 30.02亿 USD | 30.44亿 USD |
| 利息支出 | 3.47亿 USD | 3.67亿 USD | — | — | — |
| 折旧和摊销 | 4.89亿 USD | 5.55亿 USD | 5.61亿 USD | 5.78亿 USD | 5.97亿 USD |
| 营业利润 | 21.81亿 USD | 10.36亿 USD | 16.92亿 USD | 16.93亿 USD | 18.79亿 USD |
| 净利润 | 15.56亿 USD | 4.79亿 USD | 13.46亿 USD | 13.43亿 USD | 14.6亿 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$91.22
上涨空间 6.93%报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T243.29亿0.02%129.43万亿 JPY0.09%JP¥122,850+0.12%
Vanguard Morningstar Total Stock Market ETFVTI4.26亿0.02%2.3万亿 USD0.03%US$381.57-0.10%
Vanguard S&P 500 ETFVOO3.56亿0.02%1.8万亿 USD0.03%US$715.15-0.06%
Vanguard Morningstar Small-Cap ETFVB3.08亿0.16%1853亿 USD0.03%US$288.16-0.46%
Vanguard Morningstar Small-Cap Value ETFVBR1.96亿0.29%682亿 USD0.05%US$234.71+0.12%
Invesco S&P 500 Equal Weight ETFRSP1.91亿0.19%977.83亿 USD0.20%US$213.17+0.06%
iShares Core S&P 500 ETFIVV1.68亿0.02%8964.4亿 USD0.03%US$781.44-0.07%
State Street SPDR S&P 500 ETFSPY1.53亿0.02%8172亿 USD0.09%US$778.07-0.06%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Small-Cap Value ETFVBRInvesco S&P 500 Equal Weight ETFRSPiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
